Postbiotics Market - Global Forecast to 2030
商品番号 : SMB-84694
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 270 |
| 図表数 | 295 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
この調査レポートでは、ポストバイオティクス市場を、供給源（細菌および酵母）、用途（機能性食品および飲料、栄養補助食品、化粧品およびパーソナルケア製品、動物飼料、医薬品）、形態（乾燥および液体）、機能（定性的）（消化器系の健康、腸の健康、免疫系の健康、皮膚の健康、心臓の健康、その他の機能）、製造技術（定性的）（加熱不活化、噴霧乾燥、凍結乾燥、発酵由来の分画、細胞溶解および上清回収、カプセル化技術）、および地域（北米、ヨーロッパ、アジア太平洋、その他の国）別に分類しています。
本レポートは、ポストバイオティクス成分の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、各社の事業、サービス、主要戦略、契約、パートナーシップ、合意、製品発売、合併・買収、そしてポストバイオティクス市場に関連する最近の動向に関する洞察を提供しています。本レポートは、ポストバイオティクス市場エコシステムにおける新興企業の競合分析を網羅しています。さらに、技術分析、エコシステムと市場のマッピング、特許と規制の状況など、業界特有のトレンドについても調査しています。
本レポートは、市場リーダー／新規参入企業に対し、ポストバイオティクス全体およびサブセグメントの収益数値の近似値に関する情報を提供します。これにより、ステークホルダーは競争環境を理解し、自社のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めることができます。また、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供する上でも役立ちます。
ポストバイオティクス市場は2025年に1億4,670万米ドルに達すると推定され、2030年までに8.9%のCAGRで2億2,480万米ドルに達すると予測されています。
The postbiotics market is estimated at USD 146.7 million in 2025 and is projected to reach USD 224.8 million by 2030, at a CAGR of 8.9%.
The global postbiotics market is gaining significant traction, driven by increasing consumer awareness of gut health, immune support, and the demand for clean-label, shelf-stable ingredients. The growing demand for functional food & beverage products is also expected to drive the demand for the usage of postbiotic ingredients in these applications. The functional food & beverage sector has witnessed explosive growth, driven by a shift in consumer preferences toward health-enhancing everyday products. Foods fortified with ingredients that support immunity, digestion, energy, and mental clarity are now mainstream, especially in developed markets. Unlike probiotics, which require cold-chain logistics and can lose efficacy under processing conditions, postbiotics are heat-stable and shelf-stable, making them an ideal fit for beverages, high-protein bars, fermented dairy alternatives, and meal replacements. Their proven benefits in gut health and immune modulation allow brands to include science-backed claims on packaging, boosting consumer trust and driving adoption. However, consumers are less familiar with postbiotics compared to probiotics and prebiotics; thus, competition from established alternatives such as probiotics and prebiotics is expected to pose a challenge in the postbiotics market.
“Disruptions in the postbiotics market may offer opportunities for players.”
The postbiotic ingredients market is being disrupted by the development in microbial science, the shift in regulatory forces, and the growing need for safe & stable health ingredients. Postbiotics, or non-viable microbial cells or their metabolites, are becoming increasingly popular as a next-generation substitute for probiotics because of improved safety, shelf stability, and formulation flexibility. This transformation is especially evident in uses like functional foods, dietary supplements, cosmetics, and pet nutrition, where postbiotics provide distinctive benefits over live probiotics. Advances in fermentation technology and microbial inactivation are enabling developers to create customized, strain-specific postbiotic ingredients that provide specialized health benefits like gut health, immune function, and skin barrier function.
The market is also being formed by new formats and blends of products, such as synbiotic products combining probiotics, prebiotics, and postbiotics. Postbiotics are becoming a functional alternative to antibiotic growth promoters in animal nutrition, but in personal care, they are upending conventional actives in microbiome-driven skincare. Thus, the growth of personalized nutrition and microbiome testing is also allowing the creation of postbiotic solutions, further driving market evolution and differentiation.
The dietary supplement segment is projected to be one of the fastest-growing segments
Dietary supplements are a growing segment that serves the rising demand from consumers for proactive health management and preventive wellness methods. To address various functional benefits or promote general well-being, postbiotic products are designed to offer key advantages over probiotics, such as longer shelf life, no refrigeration requirement, and suitability for sensitive populations like infants and the elderly. Consumer awareness and adoption of preventative health measures are key factors propelling the rise of dietary supplements. In order to preserve optimal health and lower their risk of chronic diseases, many people are turning to supplements as a result of growing emphasis on self-care and rising healthcare costs. As a result, the market for dietary supplements has grown significantly, offering a wide range of offerings that address different health issues.
Yeast segment to grow at a significant rate among the sources in the postbiotics market
Postbiotics that are sourced from yeast hold a significant opportunity in the animal nutrition industry, particularly in the face of increasing challenges such as pathogen pressure, heat stress, high stocking densities, and the drive to reduce antibiotic use. Yeast-sourced postbiotics offer various health benefits for livestock, such as poultry, aquatic animals, as well as pets. It helps in supporting gut health, improving feed efficiency, and enhancing immunity. Additionally, as the industry is shifting toward natural solutions to maintain animal welfare and productivity, yeast-based postbiotics are gaining traction in terms of usage to improve the overall animal well-being without relying on antibiotics.
US to dominate the North American postbiotics market during forecast period
The US market is one of the largest global markets for postbiotics. Consumers in the US are becoming increasingly interested in functional food ingredients that provide certain health benefits as preventative healthcare and nutrition gain importance. This need has been driven by factors like an aging population, growing healthcare expenses, and increased awareness of the connection between nutrition and health. Furthermore, producers can now create a broad variety of postbiotic products customized to satisfy a wide range of consumer tastes due to technological improvements and innovations in food processing procedures. These factors are expected to drive the demand for postbiotics in the region.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the postbiotics market.
- By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30%
- By Designation: CXOs–20%, Managers–50%, Executives–30%
- By Region: North America–30%, Europe–25%, Asia Pacific–35%, and Rest of the World–10%
Prominent companies in the market include ADM (US), Cargill, Incorporated (US), dsm-firmenich (Netherlands), Kerry Group plc (Ireland), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), Kirin Holdings Company, Limited (Japan), Bioprox Healthcare (France), MORINAGA MILK INDUSTRY CO., LTD. (Japan), SILAB (France), Probionic Corp (Korea), Nutrignomix Sdn. Bhd. (Malaysia), Stratum Nutrition (US), BBT Biotech GmbH (Germany), and Verdesian Life Sciences (US).
Research Coverage
This research report categorizes the postbiotics market by source (bacteria and yeast), by application (functional food & beverages, dietary supplements, cosmetics & personal care products, animal feed, and pharmaceutical), by form (dry and liquid), by function (qualitative) (digestive health, gut health, immune health, skin health, heart health, and other functions), by manufacturing technology (qualitative) (heat inactivation, spray drying, lyophilization, fermentation-derived fractionation, cell lysis & supernatant recovery, and encapsulation technologies), and region (North America, Europe, Asia Pacific, and Rest of the World).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of postbiotic ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the postbiotics market. This report covers the competitive analysis of upcoming startups in the postbiotics market ecosystem. Furthermore, industry-specific trends such as technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others, are also covered in the study.
Reasons to Buy This Report
The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall postbiotics and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (rising consumer awareness of gut health and overall wellness), restraints (competition from established alternatives such as probiotics and prebiotics), opportunities (technological and economic advantages over probiotics), and challenges (regulatory uncertainty and lack of standardization) influencing the growth of the postbiotics market
- Product Development/Innovation: Detailed insights on research & development activities and new product launches in the postbiotics market
- Market Development: Comprehensive information about lucrative markets—the report analyzes postbiotics across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the postbiotics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as ADM (US), Cargill, Incorporated (US), dsm-firmenich (Netherlands), Kerry Group plc (Ireland), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), and other players in the postbiotics market.
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.3.5 UNITS CONSIDERED 30
1.4 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Breakdown of primary profiles 33
2.1.2.3 Key insights from industry experts 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 TOP-DOWN APPROACH 35
2.2.2 SUPPLY-SIDE ANALYSIS 36
2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 37
2.3 DATA TRIANGULATION AND MARKET BREAKUP 38
2.4 RESEARCH ASSUMPTIONS 39
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN POSTBIOTICS MARKET 45
4.2 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE AND COUNTRY 46
4.3 POSTBIOTICS MARKET, BY SOURCE 46
4.4 POSTBIOTICS MARKET, BY FORM 47
4.5 POSTBIOTICS MARKET, BY APPLICATION AND REGION 47
4.6 POSTBIOTICS MARKET: REGIONAL SNAPSHOT 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MACROECONOMIC INDICATORS 49
5.2.1 RISING DEMAND FOR NUTRACEUTICAL AND FUNCTIONAL FOOD 49
5.2.2 SUSTAINABILITY AND CLEAN LABEL TRENDS 50
5.3 MARKET DYNAMICS 51
5.3.1 DRIVERS 52
5.3.1.1 Rising consumer awareness of gut health and overall wellness 52
5.3.1.2 Increasing preference for natural, clean-label ingredients 53
5.3.1.3 Increasing incidence of digestive disorders and chronic health issues 53
5.3.1.4 Growing demand for functional food and beverages 53
5.3.2 RESTRAINTS 54
5.3.2.1 Competition from established alternatives like probiotics and prebiotics 54
5.3.2.2 Unclear clinical recommendations and prescription practices 54
5.3.2.3 Side effects and limited clinical safety data 54
5.3.3 OPPORTUNITIES 55
5.3.3.1 Therapeutic applications in nutrition 55
5.3.3.2 Technological and economic advantages over probiotics 56
5.3.3.3 Emerging applications in food preservation 56
5.3.3.4 Increasing R&D activities for postbiotics 57
5.3.4 CHALLENGES 58
5.3.4.1 Yield optimization, storage, and stability 58
5.3.4.2 Regulatory uncertainty and lack of standardization 59
5.3.4.3 High R&D and production costs 59
5.4 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES 60
5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 61
5.4.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 62
5.4.2.1 Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends 62
5.4.2.2 IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health 62
5.4.2.3 Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry 63
5.4.3 IMPACT OF GENERATIVE AI/AI ON POSTBIOTICS MARKET 63
5.4.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI 65
6 INDUSTRY TRENDS 66
6.1 INTRODUCTION 66
6.2 IMPACT OF 2025 US TARIFF – POSTBIOTICS MARKET 66
6.2.1 INTRODUCTION 66
6.2.2 KEY TARIFF RATES 67
6.2.3 DISRUPTION IN MICROBIAL INGREDIENTS INDUSTRY & POSTBIOTICS 67
6.2.4 PRICE IMPACT ANALYSIS 68
6.2.5 IMPACT ON COUNTRY/REGION 69
6.2.5.1 US 69
6.2.5.2 Europe 70
6.2.5.3 China 70
6.2.6 IMPACT ON END-USE INDUSTRIES 71
6.3 VALUE CHAIN ANALYSIS 72
6.3.1 RESEARCH & PRODUCT DEVELOPMENT 73
6.3.2 RAW MATERIAL SOURCING 73
6.3.3 PRODUCTION & PROCESSING 73
6.3.4 DISTRIBUTION 74
6.3.5 MARKETING & SALES 74
6.3.6 END USERS 74
6.4 TRADE ANALYSIS 74
6.4.1 IMPORT SCENARIO OF HS CODE 3002 74
6.4.2 EXPORT SCENARIO OF HS CODE 3002 76
6.5 TECHNOLOGY ANALYSIS 77
6.5.1 KEY TECHNOLOGIES 77
6.5.1.1 Heating-based inactivation technologies 77
6.5.1.2 Extraction technologies 77
6.5.1.3 Identification and characterization technologies 77
6.5.2 COMPLEMENTARY TECHNOLOGIES 78
6.5.2.1 Genomic and metabolomic profiling 78
6.5.2.2 Bioinformatics and machine learning 78
6.5.2.3 Bioprocess monitoring and automation 78
6.5.3 ADJACENT TECHNOLOGIES 78
6.5.3.1 Microbiome diagnostics: 16S rRNA sequencing 78
6.6 PRICING ANALYSIS 79
6.6.1 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER 79
6.6.2 AVERAGE SELLING PRICE TREND, BY REGION 80
6.7 ECOSYSTEM ANALYSIS 81
6.7.1 DEMAND SIDE 81
6.7.2 SUPPLY SIDE 81
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83
6.9 PATENT ANALYSIS 84
6.10 KEY CONFERENCES AND EVENTS, 2025–2026 86
6.11 REGULATORY LANDSCAPE 87
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
6.11.2 REGULATORY FRAMEWORK 88
6.11.2.1 North America 89
6.11.2.2 Europe 89
6.11.2.3 Asia Pacific 90
6.12 PORTER’S FIVE FORCES ANALYSIS 91
6.12.1 THREAT OF NEW ENTRANTS 92
6.12.2 THREAT OF SUBSTITUTES 92
6.12.3 BARGAINING POWER OF SUPPLIERS 93
6.12.4 BARGAINING POWER OF BUYERS 93
6.12.5 INTENSITY OF COMPETITIVE RIVALRY 93
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 93
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 93
6.13.2 BUYING CRITERIA 95
6.14 CASE STUDY ANALYSIS 96
6.14.1 DSM‑FIRMENICH’S STRATEGIC LEAP INTO POSTBIOTICS THROUGH ADARE BIOME ACQUISITION 96
6.14.2 ADM’S USD 30 MILLION INVESTMENT IN PROBIOTIC & POSTBIOTIC PRODUCTION FACILITY IN SPAIN 96
6.14.3 CARGILL’S ACQUISITION AND SCALE-UP OF EPICOR POSTBIOTIC INGREDIENT 97
6.15 INVESTMENT AND FUNDING SCENARIO 98
7 POSTBIOTICS MARKET, BY FUNCTION 99
7.1 INTRODUCTION 99
7.2 DIGESTIVE HEALTH 99
7.3 GUT HEALTH 100
7.4 IMMUNE HEALTH 100
7.5 SKIN HEALTH 101
7.6 HEART HEALTH 101
7.7 OTHER FUNCTIONS 102
8 POSTBIOTIC MARKET, BY MANUFACTURING TECHNOLOGY 103
8.1 INTRODUCTION 103
8.2 HEAT INACTIVATION 103
8.3 SPRAY DRYING 104
8.4 LYOPHILIZATION 104
8.5 OTHER MANUFACTURING TECHNOLOGIES 104
9 POSTBIOTICS MARKET, BY SOURCE 106
9.1 INTRODUCTION 107
9.2 BACTERIA 108
9.2.1 VERSATILITY AND WIDE-RANGING APPLICATIONS IN FUNCTIONAL FOOD, SUPPLEMENTS, AND THERAPEUTIC PRODUCTS TO DRIVE DEMAND 108
9.2.2 LACTOBACILLUS 111
9.2.3 BIFIDOBACTERIUM 111
9.2.4 OTHER BACTERIA 111
9.3 YEAST 111
9.3.1 RISING UTILIZATION IN ANIMAL HEALTHCARE AND FEED APPLICATIONS TO DRIVE MARKET 111
9.3.2 SACCHAROMYCES CEREVISIAE 113
9.3.3 SACCHAROMYCES BOULARDII 114
10 POSTBIOTICS MARKET, BY APPLICATION 115
10.1 INTRODUCTION 116
10.2 FUNCTIONAL FOOD & BEVERAGES 117
10.2.1 INCREASING FOCUS ON GUT AND IMMUNE HEALTH TO BOOST ADOPTION OF POSTBIOTIC INGREDIENTS 117
10.3 DIETARY SUPPLEMENTS 118
10.3.1 RISING EMPHASIS ON GUT AND IMMUNE HEALTH TO DRIVE DEMAND FOR POSTBIOTICS IN DIETARY SUPPLEMENTS 118
10.4 ANIMAL FEED 119
10.4.1 GROWING ADOPTION OF POSTBIOTICS IN ANIMAL FEED FOR IMPROVED HEALTH AND PERFORMANCE 119
10.5 COSMETICS & PERSONAL CARE 120
10.5.1 DEMAND FOR MICROBIOME-FRIENDLY FORMULATIONS IN COSMETICS & PERSONAL CARE TO DRIVE MARKET 120
10.6 PHARMACEUTICALS 121
10.6.1 THERAPEUTIC POTENTIAL TO DRIVE DEMAND FOR POSTBIOTICS IN PHARMACEUTICALS 121
11 POSTBIOTICS MARKET, BY FORM 123
11.1 INTRODUCTION 124
11.2 DRY 125
11.2.1 NEED FOR ENHANCED STABILITY, SHELF LIFE, AND APPLICATION FLEXIBILITY TO DRIVE DEMAND 125
11.3 LIQUID 126
11.3.1 EASE OF INCORPORATION INTO FUNCTIONAL BEVERAGES AND FERMENTED PRODUCTS TO DRIVE DEMAND 126
12 POSTBIOTICS MARKET, BY REGION 128
12.1 INTRODUCTION 129
12.2 NORTH AMERICA 131
12.2.1 US 135
12.2.1.1 Clinical innovation and evolving health needs to steer market trends 135
12.2.2 CANADA 137
12.2.2.1 Health Canada approvals and pediatric research to drive market 137
12.2.3 MEXICO 138
12.2.3.1 Rising interest in immune-supportive and gut-health formulations to drive market 138
12.3 EUROPE 140
12.3.1 GERMANY 143
12.3.1.1 Robust life sciences infrastructure and advanced industrial fermentation capabilities to drive market 143
12.3.2 UK 144
12.3.2.1 Growing interest in incorporating postbiotic ingredients into mainstream food and beverage products to boost market 144
12.3.3 FRANCE 146
12.3.3.1 Fermentation expertise and growing interest in scientifically backed microbial ingredients to drive market 146
12.3.4 ITALY 148
12.3.4.1 Increasing focus of key startups on fermentation technologies to drive market 148
12.3.5 SPAIN 149
12.3.5.1 Strategic investments in functional ingredient space to drive market 149
12.3.6 REST OF EUROPE 151
12.4 ASIA PACIFIC 153
12.4.1 CHINA 156
12.4.1.1 Growing consumer interest in gut health, functional foods, and wellness ingredients to drive market 156
12.4.2 JAPAN 158
12.4.2.1 Emphasis on gut health and functional nutrition to drive market 158
12.4.3 INDIA 159
12.4.3.1 Consumer shift toward functional and preventive nutrition products to drive market 159
12.4.4 AUSTRALIA & NEW ZEALAND 161
12.4.4.1 Increasing consumer demand for functional foods, clean-label ingredients, and gut health solutions to drive market 161
12.4.5 REST OF ASIA PACIFIC 162
12.5 REST OF THE WORLD 164
12.5.1 SOUTH AMERICA 167
12.5.1.1 Rising consumer awareness around gut health, immunity, and functional nutrition to drive market 167
12.5.2 MIDDLE EAST 169
12.5.2.1 Health and sustainability drives, including Vision 2030, to increase postbiotics adoption 169
12.5.3 AFRICA 170
12.5.3.1 Rising focus on gut health and preventive nutrition to drive market 170
13 COMPETITIVE LANDSCAPE 173
13.1 OVERVIEW 173
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–JULY 2025 173
13.3 REVENUE ANALYSIS, 2022–2024 175
13.4 MARKET SHARE ANALYSIS, 2024 176
13.5 COMPANY VALUATION AND FINANCIAL METRICS 179
13.6 BRAND/PRODUCT COMPARISON 180
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 181
13.7.1 STARS 181
13.7.2 EMERGING LEADERS 182
13.7.3 PERVASIVE PLAYERS 182
13.7.4 PARTICIPANTS 182
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 184
13.7.5.1 Company footprint 184
13.7.5.2 Regional footprint 184
13.7.5.3 Source footprint 185
13.7.5.4 Form footprint 186
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 186
13.8.1 PROGRESSIVE COMPANIES 186
13.8.2 RESPONSIVE COMPANIES 187
13.8.3 DYNAMIC COMPANIES 187
13.8.4 STARTING BLOCKS 187
13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 189
13.8.5.1 Detailed list of key startups/SMEs 189
13.8.5.2 Competitive benchmarking of key startups/SMEs 190
13.9 COMPETITIVE SCENARIO 190
13.9.1 PRODUCT LAUNCHES 190
13.9.2 DEALS 191
13.9.3 EXPANSIONS 195
14 COMPANY PROFILES 197
14.1 KEY PLAYERS 197
14.1.1 ADM 197
14.1.1.1 Business overview 197
14.1.1.2 Products/Services/Solutions offered 198
14.1.1.3 Recent developments 199
14.1.1.3.1 Deals 199
14.1.1.3.2 Expansions 199
14.1.1.3.3 Other developments 200
14.1.1.4 MnM view 200
14.1.1.4.1 Key strengths 200
14.1.1.4.2 Strategic choices 200
14.1.1.4.3 Weaknesses & competitive threats 201
14.1.2 CARGILL, INCORPORATED 202
14.1.2.1 Business overview 202
14.1.2.2 Products/Services/Solutions offered 203
14.1.2.3 Recent developments 204
14.1.2.3.1 Deals 204
14.1.2.3.2 Expansions 205
14.1.2.3.3 Other developments 205
14.1.2.4 MnM view 206
14.1.2.4.1 Key strengths 206
14.1.2.4.2 Strategic choices 206
14.1.2.4.3 Weaknesses & competitive threats 206
14.1.3 DSM-FIRMENICH 207
14.1.3.1 Business overview 207
14.1.3.2 Products/Services/Solutions offered 208
14.1.3.3 Recent developments 209
14.1.3.3.1 Deals 209
14.1.3.4 MnM view 209
14.1.3.4.1 Key strengths 209
14.1.3.4.2 Strategic choices 210
14.1.3.4.3 Weaknesses & competitive threats 210
14.1.4 KERRY GROUP PLC 211
14.1.4.1 Business overview 211
14.1.4.2 Products/Services/Solutions offered 212
14.1.4.3 Recent developments 213
14.1.4.3.1 Product launches 213
14.1.4.3.2 Deals 213
14.1.4.4 MnM view 214
14.1.4.4.1 Key strengths 214
14.1.4.4.2 Strategic choices 214
14.1.4.4.3 Weaknesses & competitive threats 214
14.1.5 ASSOCIATED BRITISH FOODS PLC 215
14.1.5.1 Business overview 215
14.1.5.2 Products/Services/Solutions offered 216
14.1.5.3 Recent developments 217
14.1.5.3.1 Deals 217
14.1.5.4 MnM view 217
14.1.5.4.1 Key strengths 217
14.1.5.4.2 Strategic choices 218
14.1.5.4.3 Weaknesses & competitive threats 218
14.1.6 BASF 219
14.1.6.1 Business overview 219
14.1.6.2 Products/Services/Solutions offered 220
14.1.6.3 Recent developments 221
14.1.6.3.1 Product launches 221
14.1.6.4 MnM view 221
14.1.7 NOVONESIS GROUP 222
14.1.7.1 Business overview 222
14.1.7.2 Products/Services/Solutions offered 223
14.1.7.3 MnM view 224
14.1.8 INTERNATIONAL FLAVORS & FRAGRANCES INC. 225
14.1.8.1 Business overview 225
14.1.8.2 Products/Services/Solutions offered 226
14.1.8.3 MnM view 227
14.1.9 MCLS EUROPE B.V. 228
14.1.9.1 Business overview 228
14.1.9.2 Products/Services/Solutions offered 228
14.1.9.3 MnM view 228
14.1.10 PHILEO BY LESAFFRE 229
14.1.10.1 Business overview 229
14.1.10.2 Products/Services/Solutions offered 229
14.1.10.3 MnM view 230
14.1.11 LALLEMAND INC. 231
14.1.11.1 Business overview 231
14.1.11.2 Products/Services/Solutions offered 231
14.1.11.3 Recent developments 232
14.1.11.3.1 Deals 232
14.1.11.4 MnM view 232
14.1.12 SAMI-SABINSA GROUP 233
14.1.12.1 Business overview 233
14.1.12.2 Products/Services/Solutions offered 233
14.1.12.3 Recent developments 234
14.1.12.3.1 Deals 234
14.1.12.4 MnM view 234
14.1.13 CJ CHEILJEDANG CORP. 235
14.1.13.1 Business overview 235
14.1.13.2 Products/Services/Solutions offered 236
14.1.13.3 Recent developments 237
14.1.13.3.1 Product launches 237
14.1.13.3.2 Deals 237
14.1.13.4 MnM view 238
14.1.14 MORINAGA MILK INDUSTRY CO., LTD. 239
14.1.14.1 Business overview 239
14.1.14.2 Products/Services/Solutions offered 240
14.1.14.3 MnM view 240
14.1.15 KIRIN HOLDINGS COMPANY, LIMITED 241
14.1.15.1 Business overview 241
14.1.15.2 Products/Services/Solutions offered 242
14.1.15.3 Recent developments 242
14.1.15.3.1 Other developments 242
14.1.15.4 MnM view 243
14.2 OTHER PLAYERS 244
14.2.1 BIOTENOVA SDN. BHD. 244
14.2.1.1 Business overview 244
14.2.1.2 Products/Services/Solutions offered 244
14.2.1.3 Recent developments 245
14.2.1.3.1 Deals 245
14.2.1.4 MnM view 245
14.2.2 BIOPROX HEALTHCARE 246
14.2.2.1 Business overview 246
14.2.2.2 Products/Services/Solutions offered 246
14.2.2.3 MnM view 247
14.2.3 SILAB 248
14.2.3.1 Business overview 248
14.2.3.2 Products/Services/Solutions offered 248
14.2.3.3 Recent developments 249
14.2.3.3.1 Expansions 249
14.2.3.4 MnM view 249
14.2.4 PROBIONIC CORP. 250
14.2.4.1 Business overview 250
14.2.4.2 Products/Services/Solutions offered 250
14.2.4.3 MnM view 250
14.2.5 NUTRIGNOMIX SDN. BHD. 251
14.2.5.1 Business overview 251
14.2.5.2 Products/Services/Solutions offered 251
14.2.5.3 MnM view 252
14.2.6 STRATUM NUTRITION 253
14.2.7 BBT BIOTECH GMBH 253
14.2.8 VERDESIAN LIFE SCIENCES 254
14.2.9 SYNBIO TECH INC. 254
14.2.10 NEO CREMAR 255
15 ADJACENT & RELATED MARKETS 256
15.1 INTRODUCTION 256
15.2 STUDY LIMITATIONS 256
15.3 FUNCTIONAL FOOD INGREDIENTS MARKET 256
15.3.1 MARKET DEFINITION 256
15.3.2 MARKET OVERVIEW 257
15.4 PROBIOTICS MARKET 258
15.4.1 MARKET DEFINITION 258
15.4.2 MARKET OVERVIEW 258
16 APPENDIX 260
16.1 DISCUSSION GUIDE 260
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266
16.3 CUSTOMIZATION OPTIONS 268
16.4 RELATED REPORTS 268
16.5 AUTHOR DETAILS 269
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES, 2020–2024 30
TABLE 2 POSTBIOTICS MARKET SNAPSHOT, 2025 VS. 2030 (USD MILLION) 41
TABLE 3 US ADJUSTED RECIPROCAL TARIFF RATES 67
TABLE 4 EXPECTED IMPACT LEVEL ON TARGET INGREDIENTS WITH RELEVANT HS CODES DUE TO US TARIFF IMPACT 69
TABLE 5 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: POSTBIOTICS MARKET 71
TABLE 6 IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 75
TABLE 7 EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 76
TABLE 8 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD) 80
TABLE 9 AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION,
2021–2024 (USD/KG) 81
TABLE 10 POSTBIOTIC MARKET: ROLE OF COMPANIES IN ECOSYSTEM 82
TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO POSTBIOTICS MARKET, 2022–2025 84
TABLE 12 POSTBIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 86
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 16 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 18 PORTER’S FIVE FORCES IMPACT ON POSTBIOTICS MARKET 91
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 94
TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 95
TABLE 21 POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 107
TABLE 22 POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 108
TABLE 23 POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 108
TABLE 24 POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 108
TABLE 25 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 109
TABLE 26 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 109
TABLE 27 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 110
TABLE 28 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 110
TABLE 29 BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 110
TABLE 30 BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 110
TABLE 31 YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 112
TABLE 32 YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 112
TABLE 33 YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 112
TABLE 34 YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 113
TABLE 35 YEAST: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 113
TABLE 36 YEAST: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 113
TABLE 37 POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 116
TABLE 38 POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 117
TABLE 39 FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 118
TABLE 40 FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 118
TABLE 41 DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 119
TABLE 42 DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 119
TABLE 43 ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 120
TABLE 44 ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 120
TABLE 45 COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 121
TABLE 46 COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 121
TABLE 47 PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 122
TABLE 48 PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 122
TABLE 49 POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 124
TABLE 50 POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 124
TABLE 51 DRY: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 125
TABLE 52 DRY: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 126
TABLE 53 LIQUID: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 126
TABLE 54 LIQUID: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 127
TABLE 55 POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 130
TABLE 56 POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 130
TABLE 57 POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 131
TABLE 58 POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 131
TABLE 59 NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 132
TABLE 60 NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 133
TABLE 61 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 133
TABLE 62 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 133
TABLE 63 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 133
TABLE 64 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 134
TABLE 65 NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 134
TABLE 66 NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 134
TABLE 67 NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 134
TABLE 68 NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 135
TABLE 69 US: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 135
TABLE 70 US: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 136
TABLE 71 US: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 136
TABLE 72 US: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 136
TABLE 73 CANADA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 137
TABLE 74 CANADA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 137
TABLE 75 CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 138
TABLE 76 CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 138
TABLE 77 MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 139
TABLE 78 MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 139
TABLE 79 MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 139
TABLE 80 MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 139
TABLE 81 EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 140
TABLE 82 EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 140
TABLE 83 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 141
TABLE 84 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 141
TABLE 85 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 141
TABLE 86 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 141
TABLE 87 EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 142
TABLE 88 EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 142
TABLE 89 EUROPE: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 142
TABLE 90 EUROPE: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 142
TABLE 91 GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 143
TABLE 92 GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 143
TABLE 93 GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144
TABLE 94 GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144
TABLE 95 UK: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 145
TABLE 96 UK: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 145
TABLE 97 UK: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 145
TABLE 98 UK: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 146
TABLE 99 FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 146
TABLE 100 FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 147
TABLE 101 FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 147
TABLE 102 FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147
TABLE 103 ITALY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 148
TABLE 104 ITALY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 148
TABLE 105 ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 149
TABLE 106 ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 149
TABLE 107 SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 150
TABLE 108 SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 150
TABLE 109 SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 150
TABLE 110 SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 150
TABLE 111 REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 151
TABLE 112 REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 151
TABLE 113 REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 152
TABLE 114 REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 152
TABLE 115 ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 154
TABLE 116 ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 154
TABLE 117 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 154
TABLE 118 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 154
TABLE 119 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 155
TABLE 120 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 155
TABLE 121 ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 155
TABLE 122 ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155
TABLE 123 ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 156
TABLE 124 ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 156
TABLE 125 CHINA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 157
TABLE 126 CHINA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 157
TABLE 127 CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 157
TABLE 128 CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 157
TABLE 129 JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 158
TABLE 130 JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 158
TABLE 131 JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 159
TABLE 132 JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 159
TABLE 133 INDIA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 160
TABLE 134 INDIA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 160
TABLE 135 INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 160
TABLE 136 INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160
TABLE 137 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE,
2021–2024 (USD MILLION) 161
TABLE 138 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 161
TABLE 139 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 162
TABLE 140 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 162
TABLE 141 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE,
2021–2024 (USD MILLION) 163
TABLE 142 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 163
TABLE 143 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 163
TABLE 144 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 164
TABLE 145 REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 164
TABLE 146 REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 165
TABLE 147 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE,
2021–2024 (USD MILLION) 165
TABLE 148 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 165
TABLE 149 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 165
TABLE 150 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 166
TABLE 151 REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 166
TABLE 152 REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 166
TABLE 153 REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM,
2021–2024 (USD MILLION) 167
TABLE 154 REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM,
2025–2030 (USD MILLION) 167
TABLE 155 SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 168
TABLE 156 SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 168
TABLE 157 SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 168
TABLE 158 SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 168
TABLE 159 MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 169
TABLE 160 MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 169
TABLE 161 MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 170
TABLE 162 MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 170
TABLE 163 AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 171
TABLE 164 AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 171
TABLE 165 AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 171
TABLE 166 AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 172
TABLE 167 OVERVIEW OF STRATEGIES ADOPTED BY KEY POSTBIOTICS MARKET PLAYERS, 2022–JULY 2025 174
TABLE 168 PLANT-BASED PROTEIN MARKET: MARKET SHARE ANALYSIS, 2024 177
TABLE 169 POSTBIOTICS MARKET: REGIONAL FOOTPRINT 184
TABLE 170 POSTBIOTICS MARKET: SOURCE FOOTPRINT 185
TABLE 171 POSTBIOTICS MARKET: FORM FOOTPRINT 186
TABLE 172 POSTBIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 189
TABLE 173 POSTBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 190
TABLE 174 POSTBIOTICS MARKET: PRODUCT LAUNCHES, JUNE 2022–MARCH 2025 190
TABLE 175 POSTBIOTICS MARKET: DEALS, DECEMBER 2022–FEBRUARY 2025 191
TABLE 176 POSTBIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2024 195
TABLE 177 ADM: COMPANY OVERVIEW 197
TABLE 178 ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 198
TABLE 179 ADM: DEALS 199
TABLE 180 ADM: EXPANSIONS 199
TABLE 181 ADM: OTHER DEVELOPMENTS 200
TABLE 182 CARGILL, INCORPORATED: COMPANY OVERVIEW 202
TABLE 183 CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 203
TABLE 184 CARGILL, INCORPORATED: DEALS 204
TABLE 185 CARGILL, INCORPORATED: EXPANSIONS 205
TABLE 186 CARGILL, INCORPORATED: OTHER DEVELOPMENTS 205
TABLE 187 DSM-FIRMENICH: COMPANY OVERVIEW 207
TABLE 188 DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 208
TABLE 189 DSM-FIRMENICH: DEALS 209
TABLE 190 KERRY GROUP PLC: COMPANY OVERVIEW 211
TABLE 191 KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 212
TABLE 192 KERRY GROUP PLC: PRODUCT LAUNCHES 213
TABLE 193 KERRY GROUP PLC: DEALS 213
TABLE 194 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW 215
TABLE 195 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 216
TABLE 196 ASSOCIATED BRITISH FOODS PLC: DEALS 217
TABLE 197 BASF: COMPANY OVERVIEW 219
TABLE 198 BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED 220
TABLE 199 BASF: PRODUCT LAUNCHES 221
TABLE 200 NOVONESIS GROUP: COMPANY OVERVIEW 222
TABLE 201 NOVONESIS GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223
TABLE 202 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW 225
TABLE 203 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 226
TABLE 204 MCLS EUROPE B.V.: COMPANY OVERVIEW 228
TABLE 205 MCLS EUROPE B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 228
TABLE 206 PHILEO BY LESAFFRE: COMPANY OVERVIEW 229
TABLE 207 PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 229
TABLE 208 LALLEMAND INC.: COMPANY OVERVIEW 231
TABLE 209 LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 231
TABLE 210 LALLEMAND INC.: DEALS 232
TABLE 211 SAMI-SABINSA GROUP: COMPANY OVERVIEW 233
TABLE 212 SAMI-SABINSA GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 233
TABLE 213 SAMI-SABINSA GROUP: DEALS 234
TABLE 214 CJ CHEILJEDANG CORP.: COMPANY OVERVIEW 235
TABLE 215 CJ CHEILJEDANG CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 236
TABLE 216 CJ CHEILJEDANG CORP.: PRODUCT LAUNCHES 237
TABLE 217 CJ CHEILJEDANG CORP.: DEALS 237
TABLE 218 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW 239
TABLE 219 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 240
TABLE 220 KIRIN HOLDINGS COMPANY, LIMITED: COMPANY OVERVIEW 241
TABLE 221 KIRIN HOLDINGS COMPANY, LIMITED: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 242
TABLE 222 KIRIN HOLDINGS COMPANY, LIMITED: OTHER DEVELOPMENTS 242
TABLE 223 BIOTENOVA SDN. BHD.: COMPANY OVERVIEW 244
TABLE 224 BIOTENOVA SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 244
TABLE 225 BIOTENOVA SDN. BHD.: DEALS 245
TABLE 226 BIOPROX HEALTHCARE: COMPANY OVERVIEW 246
TABLE 227 BIOPROX HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 246
TABLE 228 SILAB: COMPANY OVERVIEW 248
TABLE 229 SILAB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 248
TABLE 230 SILAB: EXPANSIONS 249
TABLE 231 PROBIONIC CORP.: COMPANY OVERVIEW 250
TABLE 232 PROBIONIC CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 250
TABLE 233 NUTRIGNOMIX SDN. BHD.: COMPANY OVERVIEW 251
TABLE 234 NUTRIGNOMIX SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251
TABLE 235 MARKETS ADJACENT TO POSTBIOTICS MARKET 256
TABLE 236 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2019–2023 (USD MILLION) 257
TABLE 237 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2024–2029 (USD MILLION) 257
TABLE 238 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 259
TABLE 239 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 259
LIST OF FIGURES
FIGURE 1 POSTBIOTICS MARKET: RESEARCH DESIGN 31
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 33
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 35
FIGURE 4 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 36
FIGURE 5 POSTBIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 37
FIGURE 6 DATA TRIANGULATION 38
FIGURE 7 POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 42
FIGURE 8 POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43
FIGURE 9 POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 43
FIGURE 10 POSTBIOTICS MARKET SHARE AND GROWTH RATE, BY REGION 44
FIGURE 11 INCREASING DEMAND FOR FORTIFIED AND HEALTH-POSITIONED FOODS AND BEVERAGES TO DRIVE MARKET 45
FIGURE 12 US AND BACTERIA SEGMENT TO ACCOUNT FOR SIGNIFICANT MARKET SHARES
IN 2025 46
FIGURE 13 BACTERIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 46
FIGURE 14 DRY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47
FIGURE 15 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO LEAD MARKET DURING
FORECAST PERIOD 47
FIGURE 16 US TO RECORD LARGEST MARKET SHARE IN 2025 48
FIGURE 17 POSTBIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
FIGURE 18 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS 61
FIGURE 19 POSTBIOTICS MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 20 IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 75
FIGURE 21 EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 76
FIGURE 22 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD) 79
FIGURE 23 AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION,
2021–2024 (USD/KG) 80
FIGURE 24 POSTBIOTIC MARKET: ECOSYSTEM ANALYSIS 82
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83
FIGURE 26 NUMBER OF PATENTS APPLIED AND GRANTED, 2017–2025 85
FIGURE 27 REGIONAL ANALYSIS OF PATENTS GRANTED FOR POSTBIOTICS 86
FIGURE 28 POSTBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 92
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 94
FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 95
FIGURE 31 POSTBIOTIC MARKET: INVESTMENT AND FUNDING SCENARIO 98
FIGURE 32 POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 107
FIGURE 33 POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 116
FIGURE 34 POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 124
FIGURE 35 INDIA TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD 130
FIGURE 36 NORTH AMERICA: POSTBIOTICS MARKET SNAPSHOT 132
FIGURE 37 ASIA PACIFIC: POSTBIOTICS MARKET SNAPSHOT 153
FIGURE 38 REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2022–2024 (USD BILLION) 175
FIGURE 39 MARKET SHARE ANALYSIS, 2024 177
FIGURE 40 COMPANY VALUATION 179
FIGURE 41 FINANCIAL METRICS 179
FIGURE 42 POSTBIOTICS MARKET: BRAND/PRODUCT COMPARISON 180
FIGURE 43 POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 183
FIGURE 44 POSTBIOTICS MARKET: COMPANY FOOTPRINT 184
FIGURE 45 POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 188
FIGURE 46 ADM: COMPANY SNAPSHOT 198
FIGURE 47 CARGILL, INCORPORATED: COMPANY SNAPSHOT 203
FIGURE 48 DSM-FIRMENICH: COMPANY SNAPSHOT 208
FIGURE 49 KERRY GROUP PLC: COMPANY SNAPSHOT 212
FIGURE 50 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 216
FIGURE 51 BASF: COMPANY SNAPSHOT 220
FIGURE 52 NOVONESIS GROUP: COMPANY SNAPSHOT 223
FIGURE 53 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 226
FIGURE 54 CJ CHEILJEDANG CORP.: COMPANY SNAPSHOT 236
FIGURE 55 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT 240
FIGURE 56 KIRIN HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT 242
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11